Forward Citations = 55

Loading Chart...

5 inventors (with patents filed for the assignee):

Andre Buzas (2 out of 9 patents)

Roland Ollivier (2 out of 3 patents)

Jean P Durlach (2 out of 7 patents)

4. Jean-Yves Merour (1 out of 4 patents)

5. Philippe Collery (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 4983614 - Benzhydryloxyethylpiperidine derivatives, process for their preparation (1991-01-08),

2. 4882331 - 1-[(1,1-diphenyl)-1-alkenyl]piperazine derivatives, method of (1989-11-21),

3. 4596710 - Gallium chloride as a new anti-cancerous drug (1986-06-24),

4. 4355043 - Novel derivatives of 3-aminopropanesulfonic acid having a reinforced (1982-10-19),

5. 4271189 - Lithium derivatives of taurine having reinforced neuro-muscular activity (1981-06-02),

Company Overview

Les Laboratoires Meram is a leading pharmaceutical company specializing in the research, development, and production of high-quality medications. With a focus on innovation and customer satisfaction, we strive to improve the health and well-being of individuals worldwide. Our cutting-edge products and commitment to excellence have earned us a reputation as a trusted partner in the healthcare industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#568 in Paris

#2,868 in France

Paris, France

Les Laboratoires Meram

Forward Citations = 55

5 inventors:

Andre Buzas (2 out of 9 patents)

Roland Ollivier (2 out of 3 patents)

Jean P Durlach (2 out of 7 patents)

4. Jean-Yves Merour (1 out of 4 patents)

5. Philippe Collery (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Les Laboratoires Meram. Retrieved from https://idiyas.com/company/les-laboratoires-meram

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]